CYLD anticorps
-
- Antigène Voir toutes CYLD Anticorps
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CYLD est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human CYLD
- Isotype
- IgG
- Top Product
- Discover our top product CYLD Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.7 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Conseil sur la manipulation
- Avoid freeze / thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Autre désignation
- CYLD (CYLD Produits)
- Synonymes
- anticorps BRSS, anticorps CDMT, anticorps CYLD1, anticorps CYLDI, anticorps EAC, anticorps MFT, anticorps MFT1, anticorps SBS, anticorps TEM, anticorps USPL2, anticorps 2010013M14Rik, anticorps 2900009M21Rik, anticorps C130039D01Rik, anticorps mKIAA0849, anticorps cyld, anticorps LRRGT00003, anticorps Rp1, anticorps Rp1h, anticorps CYLD lysine 63 deubiquitinase, anticorps cylindromatosis (turban tumor syndrome), a, anticorps CYLD, anticorps Cyld, anticorps cylda
- Sujet
- This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
- NCBI Accession
- NP_056062
- Pathways
- Apoptose, Activation of Innate immune Response
-